Mon panier

IL-10 R alpha

IL-10 R alpha Informations sur la molécule

Nom anglaisInterleukin 10 receptorNombre de médicaments commercialisés0
Nombre de médicaments cliniques9Alias de la cibleReceptors, Interleukin-10
Phase de R&D la plus avancéePhase 3 Clinical
Nom anglaisInterleukin 10 receptor
Alias de la cibleReceptors, Interleukin-10
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques9
Phase de R&D la plus avancéePhase 3 Clinical

IL-10 R alpha Liste de produits

  • Attribut

    Protein (4)

  • Bibliothèque de produits

    En ligne (4)

  • Espèces

    Human (2)Cynomolgus (1)Mouse (1)

  • Étiquette

    Fc Tag & Avi Tag (1)Fc Tag (3)

  • Marqueur

    Biotin-labeled (1)Unconjugated (3)

IL-10 R alphaAlias de la molécule

Interleukin-10 receptor subunit alpha,IL-10 receptor subunit alpha,IL-10R subunit alpha,IL-10RA,CDw210a,Interleukin-10 receptor subunit 1,IL-10R subunit 1,IL-10R1,CD210,IL10RA,IL10R

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
IAE-0972IAE-0972Phase 3 ClinicalSunHo (China) BioPharmaceutical Co LtdCarcinoma, Basosquamous; Carcinoma, Hepatocellular; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
Recombinant anti-human EGFR antibody/IL-10 bispecific Fc fusion protein(Dingfu Biotarget)CmAb-(IL10)2; DF203; DF-203Phase 2 ClinicalDingfu Biotarget Co LtdAscites; Pleural Effusion, Malignant; Solid tumours
Details
AG-019AG-019Phase 2 ClinicalPrecigen Actobio IncDiabetes Mellitus, Type 1
Details
Meta 10C-IL-10 TILsMeta10-TIL; Meta 10C-IL-10 TILsPhase 2 ClinicalLeman Biotech Co LtdNeoplasms; Solid tumours
Details
IBB-0979IBB0979; IBB-0979Phase 2 ClinicalSunHo (China) BioPharmaceutical Co LtdCarcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
VimekofuspAMT-101 (Applied Molecular Transport)Phase 2 ClinicalApplied Molecular TransportColitis, Ulcerative
Details
F8-IL10F8-IL10; PF-06687234Phase 2 ClinicalPhilogen SpaArthritis, Rheumatoid; Colitis, Ulcerative; Inflammatory Bowel Diseases
Details
PEG-ilodecakinAM-0010Phase 1 ClinicalArmo Biosciences, Merck Sharp & Dohme CorpBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Granulomatosis with Polyangiitis; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Vasculitis
Details
Diakine-DK2 10 (EGFR)DK210; DK-2-10Phase 1 ClinicalDeka Biosciences IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Kidney Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Solid tumours
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques